Billionaire Johann Rupert officially takes full control of South African private hospital giant

Billionaire Johann Rupert’s South African investment vehicle, Remgro, has officially taken full control of Mediclinic Holdings’ Southern Africa business unit.

This marks the end of a complex deal between Remgro and Luxembourg-based Investment Holding Limited (IHL) to divide their shared stake in Mediclinic Holdings.

First announced in December 2025, this transaction has had to jump through multiple regulatory hoops, both in South Africa and Europe, to reach completion.

Previously, Remgro and IHL were co-shareholders in Mediclinic Holdings, each holding 50% of the healthcare giant.

The companies announced in December that they had reached an agreement to split their stakes.

This transaction sees Remgro owning 100% of the group’s Southern Africa operations, held in Mediclinic International, and IHL owning 100% of the Swiss-based operations, housed in the Hirslanden Group.

To facilitate the transaction, the companies had to receive regulatory approval and meet conditions in both South Africa and Europe.

South Africa’s Competition Tribunal gave Remgro the green light in mid-June 2026, and on Wednesday, 1 July, the company announced that all other conditions had been fulfilled.

Initially, it was expected that both Remgro and IHL would pay $950 million (R15.61 billion) for their respective acquisitions.

However, due to leakages and accruals that occurred between the transaction’s announcement and now, Remgro ended up paying $947 million (R15.56 billion), while IHL paid $1.08 billion (R17.74 billion).

With all the conditions fulfilled and the money paid, this complex transaction is complete, and Remgro now has full control over Mediclinic’s Southern Africa operations.

The company previously said this setup makes more sense than the previous holding structure, as Remgro and IHL can now help Mediclinic succeed in their respective regions.

It will allow each company to tailor their strategies to better align with regional market dynamics, positioning them for greater value, stronger local partnerships, and greater brand presence.

“Remgro and IHL remain strongly aligned in their common desire to invest for the long term in the private healthcare sector broadly,” the South African investment giant said.